» Articles » PMID: 23179793

Multiple Small "imaging" Branch-duct Type Intraductal Papillary Mucinous Neoplasms (IPMNs) in Familial Pancreatic Cancer: Indicator for Concomitant High Grade Pancreatic Intraepithelial Neoplasia?

Overview
Journal Fam Cancer
Publisher Springer
Specialty Oncology
Date 2012 Nov 27
PMID 23179793
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Most screening programs for familial pancreatic cancer are currently based on endoscopic ultrasonography and/or magnetic resonance imaging (MRI). Cystic lesions, especially those suspicious for small intraductal pancreatic mucinous neoplasms (IPMNs) of the branch ducts, can be visualized in up to 40 % of individuals at risk, but their pathological importance in the setting of FPC is yet not well established. Individuals at risk from a prospective screening program for familial pancreatic cancer with small "imaging" IPMNs of the branch-duct type (BD-IPMN) who underwent pancreatic resection were analysed regarding clinico-pathological data and the locations of pancreatic lesions. Five of 125 individuals at risk who underwent screening had multiple small (size 2-10 mm) unicystic lesions and/or multicystic single lesions in the pancreatic body and tail suspicious for BD-IPMNs upon MRI imaging and decided to undergo surgical resection after interdisciplinary counselling, although none fulfilled the consensus criteria for IPMN resection. Histological examination revealed BD-IPMNs with low or moderate dysplasia of the gastric type in combination with multifocal PanIN2 and PanIN3 lesions in 4 individuals. The remaining patient had only tiny ductectasias in the pancreatic tail with multifocal PanIN 2 lesions in the entire gland and one PanIN3 lesion in the pancreatic head. Intriguingly, the location of the most dysplastic histological lesions (PanIN3) did not correspond to the preoperatively detected lesions and were not visible in preoperative imaging. In the setting of FPC, the presence of multiple small "imaging" BD-IPMNs may indicate the presence of high-grade PanIN lesions elsewhere in the pancreas.

Citing Articles

Surgical aspects related to hereditary pancreatic cancer.

Maurer E, Bartsch D Fam Cancer. 2024; 23(3):341-350.

PMID: 38662263 PMC: 11254980. DOI: 10.1007/s10689-024-00384-1.


Pancreatic Cysts Greater Than 1 cm Are Associated With an Increased Risk for Developing Pancreatic Cancer in Individuals From Pancreatic-Cancer Prone Kindreds Undergoing Surveillance.

Aijazi M, Fasanella K, McGrath K, Smith L, Singhi A, Brand R Pancreas. 2024; 53(4):e350-e356.

PMID: 38518061 PMC: 10963034. DOI: 10.1097/MPA.0000000000002312.


Endoscopic Ultrasound Can Differentiate High-Grade Pancreatic Intraepithelial Neoplasia, Small Pancreatic Ductal Adenocarcinoma, and Benign Stenosis.

Sagami R, Yamao K, Minami R, Nakahodo J, Akiyama H, Nishikiori H Gut Liver. 2023; 18(2):338-347.

PMID: 37165770 PMC: 10938144. DOI: 10.5009/gnl220521.


Characteristics of familial pancreatic cancer families with additional colorectal carcinoma.

Lehman B, Matthai E, Gercke N, Denzer U, Figiel J, Hess T Fam Cancer. 2023; 22(3):323-330.

PMID: 36717525 PMC: 10276072. DOI: 10.1007/s10689-023-00328-1.


Current Screening Strategies for Pancreatic Cancer.

Vanek P, Urban O, Zoundjiekpon V, Falt P Biomedicines. 2022; 10(9).

PMID: 36140157 PMC: 9495594. DOI: 10.3390/biomedicines10092056.


References
1.
Verna E, Hwang C, Stevens P, Rotterdam H, Stavropoulos S, Sy C . Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics. Clin Cancer Res. 2010; 16(20):5028-37. DOI: 10.1158/1078-0432.CCR-09-3209. View

2.
Bussom S, Saif M . Intraductal papillary mucinous neoplasia (IPMN). Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010. JOP. 2010; 11(2):131-4. View

3.
Jones S, Hruban R, Kamiyama M, Borges M, Zhang X, Parsons D . Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science. 2009; 324(5924):217. PMC: 2684332. DOI: 10.1126/science.1171202. View

4.
Bartsch D, Sina-Frey M, Ziegler A, Hahn S, Przypadlo E, Kress R . Update of familial pancreatic cancer in Germany. Pancreatology. 2002; 1(5):510-6. DOI: 10.1159/000055853. View

5.
Brune K, Abe T, Canto M, OMalley L, Klein A, Maitra A . Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol. 2006; 30(9):1067-76. PMC: 2746409. DOI: pas.0000213265.84725.0b. View